Medtrum France

Medtrum France, founded in 2014, is a private medical device company specializing in the development of automated insulin delivery systems for diabetes care. The company's technology platform integrates its proprietary insulin patch pumps with continuous glucose monitoring to create a hybrid closed-loop system aimed at improving glycemic control. Operating from Vienna, Austria, it targets the growing global market for diabetes management technologies, competing against larger, established players by focusing on user-friendly, connected solutions. As a commercial-stage company, it generates revenue through the sale of its medical devices and associated disposables.

Integrated Hybrid Closed-Loop system combining a tubeless insulin patch pump, continuous glucose monitor (CGM), and smartphone app with predictive algorithms for automated basal insulin delivery.

Medtrum operates in a highly competitive market dominated by giants like Medtronic (MiniMed), Insulet (Omnipod), and Tandem Diabetes Care (t:slim). It competes primarily on the basis of its tubeless patch pump form factor and integrated ecosystem, often targeting a more cost-sensitive segment. It also faces competition from other patch pump developers and emerging digital health platforms integrating with multiple devices.